Cargando…

Left Heart Dysfunction in Acromegaly Revealed by Novel Echocardiographic Methods

Background: Acromegaly is a rare disease that requires modern treatment to decrease the risk of mortality, mainly from vascular diseases. Identifying acromegalic patients with increased cardiovascular risk is challenging. Speckle-tracking echocardiography (STE) is a modern, well-validated, and repro...

Descripción completa

Detalles Bibliográficos
Autores principales: Uziȩbło-Życzkowska, Beata, Jurek, Agnieszka, Witek, Przemysław, Zieliński, Grzegorz, Gielerak, Grzegorz, Krzesiński, Paweł
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326767/
https://www.ncbi.nlm.nih.gov/pubmed/32670201
http://dx.doi.org/10.3389/fendo.2020.00418
_version_ 1783552405459173376
author Uziȩbło-Życzkowska, Beata
Jurek, Agnieszka
Witek, Przemysław
Zieliński, Grzegorz
Gielerak, Grzegorz
Krzesiński, Paweł
author_facet Uziȩbło-Życzkowska, Beata
Jurek, Agnieszka
Witek, Przemysław
Zieliński, Grzegorz
Gielerak, Grzegorz
Krzesiński, Paweł
author_sort Uziȩbło-Życzkowska, Beata
collection PubMed
description Background: Acromegaly is a rare disease that requires modern treatment to decrease the risk of mortality, mainly from vascular diseases. Identifying acromegalic patients with increased cardiovascular risk is challenging. Speckle-tracking echocardiography (STE) is a modern, well-validated, and reproducible method of assessing left ventricular longitudinal deformation and providing a sensitive assessment of myocardial contractility. We hypothesized that STE may be useful in evaluating subclinical dysfunction of the left heart in acromegalic patients, especially when a left ventricle (LV) assessment is completed with STE of the left atrium (LA). Purpose: To assess the diagnostic value of speckle-tracking echocardiography in identifying the occurrence of LV and LA functional impairment in patients with acromegaly, in comparison to patients without this rare pituitary disease. Methods: Echocardiographic assessments of LV and LA function using the new STE method were performed in 60 subjects: 30 acromegalic (ACRO group) patients and a CONTROL group with 30 patients matched in terms of age, gender, systolic/diastolic pressure, and history of hypertension for at least 12 months. Results: The ACRO group, compared to the CONTROL group, presented: (1) higher left ventricular mass (left ventricular mass index: 132 vs. 108 g/m(2), p < 0.001) and, in consequence, more frequent LV hypertrophy (80.0 vs. 53.3%; p = 0.028); (2) impaired LV systolic function measured by both left ventricular ejection fraction (LVEF) (63.4 vs. 66.9%, p < 0.001) and global longitudinal strain (GLS) (−18.1 vs. −19.4%, p = 0.023); (3) greater LA anteroposterior diameter (40.3 vs. 36.9 mm, p = 0.003) and indexed left atrial volume (37.9 vs. 27.6 ml/m(2), p < 0.001); and (4) impaired echocardiographic strain parameters corresponding with LA function. Conclusions: Acromegaly, even in young patients with good blood pressure control, may be associated with left ventricular hypertrophy and subclinical impairment of the left ventricular and left atrial mechanical function, which may be identified by speckle-tracking echocardiography. Further research in this area is necessary to clarify the prognostic value of these phenomena.
format Online
Article
Text
id pubmed-7326767
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-73267672020-07-14 Left Heart Dysfunction in Acromegaly Revealed by Novel Echocardiographic Methods Uziȩbło-Życzkowska, Beata Jurek, Agnieszka Witek, Przemysław Zieliński, Grzegorz Gielerak, Grzegorz Krzesiński, Paweł Front Endocrinol (Lausanne) Endocrinology Background: Acromegaly is a rare disease that requires modern treatment to decrease the risk of mortality, mainly from vascular diseases. Identifying acromegalic patients with increased cardiovascular risk is challenging. Speckle-tracking echocardiography (STE) is a modern, well-validated, and reproducible method of assessing left ventricular longitudinal deformation and providing a sensitive assessment of myocardial contractility. We hypothesized that STE may be useful in evaluating subclinical dysfunction of the left heart in acromegalic patients, especially when a left ventricle (LV) assessment is completed with STE of the left atrium (LA). Purpose: To assess the diagnostic value of speckle-tracking echocardiography in identifying the occurrence of LV and LA functional impairment in patients with acromegaly, in comparison to patients without this rare pituitary disease. Methods: Echocardiographic assessments of LV and LA function using the new STE method were performed in 60 subjects: 30 acromegalic (ACRO group) patients and a CONTROL group with 30 patients matched in terms of age, gender, systolic/diastolic pressure, and history of hypertension for at least 12 months. Results: The ACRO group, compared to the CONTROL group, presented: (1) higher left ventricular mass (left ventricular mass index: 132 vs. 108 g/m(2), p < 0.001) and, in consequence, more frequent LV hypertrophy (80.0 vs. 53.3%; p = 0.028); (2) impaired LV systolic function measured by both left ventricular ejection fraction (LVEF) (63.4 vs. 66.9%, p < 0.001) and global longitudinal strain (GLS) (−18.1 vs. −19.4%, p = 0.023); (3) greater LA anteroposterior diameter (40.3 vs. 36.9 mm, p = 0.003) and indexed left atrial volume (37.9 vs. 27.6 ml/m(2), p < 0.001); and (4) impaired echocardiographic strain parameters corresponding with LA function. Conclusions: Acromegaly, even in young patients with good blood pressure control, may be associated with left ventricular hypertrophy and subclinical impairment of the left ventricular and left atrial mechanical function, which may be identified by speckle-tracking echocardiography. Further research in this area is necessary to clarify the prognostic value of these phenomena. Frontiers Media S.A. 2020-06-24 /pmc/articles/PMC7326767/ /pubmed/32670201 http://dx.doi.org/10.3389/fendo.2020.00418 Text en Copyright © 2020 Uziȩbło-Życzkowska, Jurek, Witek, Zieliński, Gielerak and Krzesiński. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Uziȩbło-Życzkowska, Beata
Jurek, Agnieszka
Witek, Przemysław
Zieliński, Grzegorz
Gielerak, Grzegorz
Krzesiński, Paweł
Left Heart Dysfunction in Acromegaly Revealed by Novel Echocardiographic Methods
title Left Heart Dysfunction in Acromegaly Revealed by Novel Echocardiographic Methods
title_full Left Heart Dysfunction in Acromegaly Revealed by Novel Echocardiographic Methods
title_fullStr Left Heart Dysfunction in Acromegaly Revealed by Novel Echocardiographic Methods
title_full_unstemmed Left Heart Dysfunction in Acromegaly Revealed by Novel Echocardiographic Methods
title_short Left Heart Dysfunction in Acromegaly Revealed by Novel Echocardiographic Methods
title_sort left heart dysfunction in acromegaly revealed by novel echocardiographic methods
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326767/
https://www.ncbi.nlm.nih.gov/pubmed/32670201
http://dx.doi.org/10.3389/fendo.2020.00418
work_keys_str_mv AT uziebłozyczkowskabeata leftheartdysfunctioninacromegalyrevealedbynovelechocardiographicmethods
AT jurekagnieszka leftheartdysfunctioninacromegalyrevealedbynovelechocardiographicmethods
AT witekprzemysław leftheartdysfunctioninacromegalyrevealedbynovelechocardiographicmethods
AT zielinskigrzegorz leftheartdysfunctioninacromegalyrevealedbynovelechocardiographicmethods
AT gielerakgrzegorz leftheartdysfunctioninacromegalyrevealedbynovelechocardiographicmethods
AT krzesinskipaweł leftheartdysfunctioninacromegalyrevealedbynovelechocardiographicmethods